Craig Malzahn reports a stock award at Regenxbio
By AlphaYouPublished Form 4
Malzahn Craig
Reporting filer
Craig Malzahn reports a stock award, not an open-market purchase or sale, in REGENXBIO Inc.. Form 4 filed Nov 3, 2026 lists 1 entry.
- Disclosed
- Nov 3, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Malzahn Craig | 2026-11-01 | A | Grant or award | 27777.00 | 0.00 | 109,737 | 2 days | Filed terms
|
Common Stock
- Owner
- Malzahn Craig
- Date
- 2026-11-01
- Code
- A
- Action
- Grant or award
- Quantity
- 27777.00
- Price
- 0.00
- Following holdings
- 109,737
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-01
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Timeliness:
- transaction Shares: 27777.00
- id: F1
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 109737.00
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Malzahn Craig: Chief Technology Officer.
- F1: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 1/3rd of the shares subject to the RSU award shall vest on each of November 1, 2027, November 1, 2028, and November 1, 2029, while the recipient provides continuous service to the Issuer.
Original sources
Prepared automatically from public filing data. Report a correction.